Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 118,713 | 124,961 | 152,069 | 156,234 | 111,014 |
| Cost of Goods | 35,383 | 39,227 | 27,020 | 18,748 | 15,832 |
| Gross Profit | 83,330 | 85,734 | 125,049 | 137,486 | 95,182 |
| Operating Expenses | 105,249 | 110,437 | 368,605 | 98,829 | 86,590 |
| Operating Income | -21,536 | -24,476 | -243,536 | 39,405 | 9,424 |
| Interest Expense | 3,075 | 3,039 | 3,380 | 7,961 | 10,220 |
| Other Income | -5,329 | 5,986 | -7,138 | -278 | 243 |
| Pre-tax Income | -29,940 | -21,529 | -254,054 | 31,166 | -553 |
| Income Tax | 435 | 52 | 77,888 | -78,459 | 728 |
| Net Income Continuous | -30,375 | -21,581 | -331,942 | 109,625 | -1,281 |
| Net Income | $-30,375 | $-21,581 | $-331,942 | $109,625 | $-1,281 |
| EPS Basic Total Ops | -4.74 | -3.40 | -70.02 | 34.93 | -0.45 |
| EPS Basic Continuous Ops | -4.74 | -3.40 | -70.06 | 34.97 | -0.44 |
| EPS Diluted Total Ops | -4.74 | -3.40 | -70.02 | 30.43 | -0.45 |
| EPS Diluted Continuous Ops | -4.74 | -3.40 | -70.06 | 30.06 | -0.44 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.45 | 6.75 | 30.43 | -0.45 |
| EBITDA(a) | $8,944 | $1,792 | $-214,852 | $73,105 | $38,695 |